NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 159 filers reported holding NUVALENT INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $346,807,493 | +10.5% | 4,571,678 | +9.4% | 13.27% | +20.2% |
| Q1 2024 | $313,713,255 | +10.5% | 4,177,830 | +8.3% | 11.04% | -16.9% |
| Q4 2023 | $283,910,809 | +277.0% | 3,858,008 | +135.5% | 13.29% | +160.1% |
| Q3 2023 | $75,305,618 | +59.4% | 1,638,147 | +46.2% | 5.11% | +40.0% |
| Q2 2023 | $47,250,009 | – | 1,120,465 | – | 3.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $1,516,519,081 | 25.23% |
| Bain Capital Life Sciences Investors, LLC | 2,697,267 | $204,614,675 | 22.46% |
| Fairmount Funds Management LLC | 1,924,626 | $146,002,128 | 16.50% |
| Paradigm Biocapital Advisors LP | 4,571,678 | $346,807,493 | 13.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 465,710 | $35,328,761 | 8.34% |
| COMMODORE CAPITAL LP | 1,487,756 | $112,861,170 | 7.70% |
| Perceptive Advisors | 2,549,077 | $193,372,981 | 4.66% |
| Boxer Capital, LLC | 1,120,192 | $84,977,765 | 4.48% |
| First Turn Management, LLC | 252,276 | $19,137,657 | 3.11% |
| Ikarian Capital, LLC | 151,601 | $11,500,452 | 2.00% |